PURPOSE: To describe the preliminary results after intraoperative radiotherapy (IORT) with the photon radiosurgery system in children with recurrent brain tumors treated at the first dose level (10 Gy) of a Phase I protocol. METHODS AND MATERIALS: A Phase I IORT dose escalation protocol was initiated at Children's Memorial Hospital to determine the maximal tolerated IORT dose in children with recurrent brain tumors. RESULTS: Fourteen children have received IORT thus far. Eight had been previously irradiated. Thirteen children had ependymoma. The median follow-up was 16 months. Three patients (21%) developed radiation necrosis on follow-up MRI scans 6 to 12 months after IORT. They had not been previously irradiated and had received 10 Gy to a depth of 5 mm. One required surgery and the other two had resolution of their lesions without treatment. All 3 patients were asymptomatic at the last follow-up. No other late toxicity was observed at the last follow-up visit. Eight patients (57%) had tumor control within the surgical bed after IORT. CONCLUSION: Our findings have demonstrated the safety and feasibility of IORT to a dose of 10 Gy to 2 mm in children with previously irradiated brain tumors. IORT to a dose of 10 Gy at 5 mm was associated with a greater complication rate.
PURPOSE: To describe the preliminary results after intraoperative radiotherapy (IORT) with the photon radiosurgery system in children with recurrent brain tumors treated at the first dose level (10 Gy) of a Phase I protocol. METHODS AND MATERIALS: A Phase I IORT dose escalation protocol was initiated at Children's Memorial Hospital to determine the maximal tolerated IORT dose in children with recurrent brain tumors. RESULTS: Fourteen children have received IORT thus far. Eight had been previously irradiated. Thirteen children had ependymoma. The median follow-up was 16 months. Three patients (21%) developed radiation necrosis on follow-up MRI scans 6 to 12 months after IORT. They had not been previously irradiated and had received 10 Gy to a depth of 5 mm. One required surgery and the other two had resolution of their lesions without treatment. All 3 patients were asymptomatic at the last follow-up. No other late toxicity was observed at the last follow-up visit. Eight patients (57%) had tumor control within the surgical bed after IORT. CONCLUSION: Our findings have demonstrated the safety and feasibility of IORT to a dose of 10 Gy to 2 mm in children with previously irradiated brain tumors. IORT to a dose of 10 Gy at 5 mm was associated with a greater complication rate.
Authors: John A Vargo; Kristie M Sparks; Rahul Singh; Geraldine M Jacobson; Joshua D Hack; Christopher P Cifarelli Journal: J Neurooncol Date: 2018-08-09 Impact factor: 4.130
Authors: Tomasz Rutkowski; Andrzej Wygoda; Marcin Hutnik; Krzysztof Składowski; Jerzy Wydmański; Adam Maciejewski; Cezary Szymczyk; Janusz Wierzgoń; Andrzej Orlef; Bogusław Maciejewski Journal: Strahlenther Onkol Date: 2010-08-30 Impact factor: 3.621
Authors: Frank A Giordano; Stefanie Brehmer; Yasser Abo-Madyan; Grit Welzel; Elena Sperk; Anke Keller; Frank Schneider; Sven Clausen; Carsten Herskind; Peter Schmiedek; Frederik Wenz Journal: BMC Cancer Date: 2014-12-22 Impact factor: 4.430
Authors: Afsoun Seddighi; Mohammad Esmaeil Akbari; Amir Saied Seddighi; Afshin Rakhsha; Marjan Vaezi; Amir Hossein Zohrevand Journal: Iran J Cancer Prev Date: 2015-10-27
Authors: Motaz Hamed; Anna-Laura Potthoff; Julian P Layer; David Koch; Valeri Borger; Muriel Heimann; Davide Scafa; Gustavo R Sarria; Jasmin A Holz; Frederic Carsten Schmeel; Alexander Radbruch; Erdem Güresir; Niklas Schäfer; Patrick Schuss; Stephan Garbe; Frank A Giordano; Ulrich Herrlinger; Hartmut Vatter; Leonard Christopher Schmeel; Matthias Schneider Journal: Cancers (Basel) Date: 2022-03-16 Impact factor: 6.639